ECRI

Call Directions Website Contact the practice

ECRI An independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings worldwide

For nearly 50 years, ECRI Institute, a nonprofit organization, has been dedicated to bringing the discipline of applied scientific research to discover which medical procedures, devices, drugs, and processes are best, all to enable you to improve patient care. We firmly believe that seeking and finding the best ways to improve patient care require "The Discipline of Science" and "The Integrity of Independence."

👁️ Could gene therapy offer a new treatment option for inherited vision loss?Laruparetigene zovaparvovec (laru-zova) is ...
03/11/2026

👁️ Could gene therapy offer a new treatment option for inherited vision loss?

Laruparetigene zovaparvovec (laru-zova) is an investigational gene therapy designed to deliver functional copies of the RPGR gene to retinal cells in patients with X-linked retinitis pigmentosa (XLRP).

Why this matters:
· XLRP causes progressive vision loss, with no disease-modifying treatments currently approved by the US Food and Drug Administration (FDA).
· Laru-zova aims to restore production of RPGR protein, which is essential for photoreceptor function.
· In a late-stage clinical trial, laru-zova was reported to improve low-luminance visual acuity among patients who received a high dose.

📖 Want to know more? Explore the full story in our latest Emerging Health Care Innovation Brief. ➡️ Read the brief: https://hubs.la/Q04CWBXm0

In comments submitted to the Centers for Medicare & Medicaid Services, ECRI has expressed support for the proposed RAPID...
23/10/2026

In comments submitted to the Centers for Medicare & Medicaid Services, ECRI has expressed support for the proposed RAPID coverage pathway’s goal of accelerating patient access to breakthrough medical devices. At the same time, ECRI emphasized that coverage decisions should remain grounded in evidence demonstrating meaningful clinical benefit and safety for Medicare beneficiaries.

ECRI’s recommendations to help the safest, most effective devices reach patients quickly include:
- Ensure studies adequately represent older adults and patients with comorbidities
- Require defined post-market surveillance and evidence development
- Incorporate human factors engineering into the evidence framework
- Address healthcare accessibility and equity considerations

Read ECRI’s full comments: https://hubs.la/Q04C3XC-0

22/10/2026

The latest report from the HHS Physician-Focused Payment Model Technical Advisory Committee (PTAC) (https://hubs.ly/Q04Bq0Fh0) highlights the need for new strategies to reduce preventable harm. Earlier this year, ECRI's Chief Medical Officer Dheerendra Kommala (https://hubs.ly/Q04Bq0sN0), MD, was invited to participate in the committee's public discussion on how alternative payment models can better support patient safety.

During the session, he emphasized opportunities to strengthen near-miss reporting, improve care transitions, adopt technologies that enhance safety, and apply human factors engineering principles to prevent patient harm.

PTAC's subsequent report to HHS underscores persistent challenges related to preventable harm and underreporting, while encouraging innovative approaches to improving outcomes across care settings.

📖 Read the report: https://hubs.ly/Q04Bq0sM0

Patients move from one provider to another far more easily than their medical information does. When patients transition...
21/10/2026

Patients move from one provider to another far more easily than their medical information does. When patients transition across care settings, critical clinical information does not reliably travel with them. The result is one patient with dozens of incomplete, unreconciled records.

ECRI President and CEO Marcus Schabacker, MD, PhD, advocates for a “One Patient, One Record” system to give clinicians the complete, timely intelligence they need to make informed decisions, avoid delays, and deliver safer care.

👉 Read more: https://hubs.ly/Q04BpZQ50

Award-Winning Research 🏆Christie Bergerson, PhD, presented an ECRI study at   on factors that can shape how AI tools for...
20/10/2026

Award-Winning Research 🏆

Christie Bergerson, PhD, presented an ECRI study at on factors that can shape how AI tools for wound care are developed and evaluated, helping advance conversations around safe, reliable, and responsible use of AI.

Her presentation, "Characterizing Dataset Bias and Contextual Confounding in a Public Wound Image Database: Implications for Safe and Reliable Medical AI Use," earned the 2026 Marie Brown Etris 2nd Place Oral Abstract Award, selected from 355 accepted abstracts. The research team also included Jim Martucci, Sandra Myint, RN, and Scott Lucas, PhD, PE.

Congratulations to the team on receiving this honor from the Symposium on Advanced Wound Care (SAWC)! 👏

For more ECRI resources on AI: https://hubs.la/Q04BKX9F0

🧬 Could a new treatment improve motor function in people with spinal muscular atrophy?Apitegromab-mstn (Isembyld) is a h...
14/10/2026

🧬 Could a new treatment improve motor function in people with spinal muscular atrophy?

Apitegromab-mstn (Isembyld) is a human monoclonal antibody approved as an add on treatment to improve motor function in patients aged 2 years or older with spinal muscular atrophy (SMA) who are receiving SMN2–targeted therapy.

Why this matters:
· SMA causes progressive muscle weakness and atrophy, and existing disease-modifying therapies do not reverse impairment caused by established neurodegeneration.
· Apitegromab is designed to mitigate residual muscle weakness by improving muscle function in patients already receiving SMN2–targeted therapy.
· In a phase 3 trial, apitegromab improved motor function through week 52 compared with placebo. The US Food and Drug Administration (FDA) approved apitegromab in September of 2026.

📖 Want to know more? Explore the full story in our latest Emerging Health Care Innovation Brief (Vol. 4 | Issue 20). ➡️ Read the brief: https://hubs.la/Q04zXWXR0

ECRI Vice President of Devices, Therapeutics, and Technology Scott Lucas recently visited Cottage Health in Santa Barbar...
13/10/2026

ECRI Vice President of Devices, Therapeutics, and Technology Scott Lucas recently visited Cottage Health in Santa Barbara to present the team with the 2026 Health Technology Excellence Award.

It was a privilege to celebrate the people behind Cottage Health's interfacility blood transfer program. Their work ensures red blood cell units are used before they expire, honoring every donor's gift while generating nearly half a million dollars in savings.

Thank you to the Cottage Health team for welcoming us and for setting a new standard in resource stewardship. 👏

👉 Learn how they did it: https://hubs.la/Q04zXSDg0

Has an AI tool ever given you an output that didn't look right? Report it to ECRI’s Problem Reporting Network (PRN). We ...
07/10/2026

Has an AI tool ever given you an output that didn't look right? Report it to ECRI’s Problem Reporting Network (PRN). We have expanded the PRN to capture suspected AI-related errors, incorrect outputs, and unsafe AI behavior in clinical or operational settings.

Reporting is confidential, and our clinical and engineering experts review every submission. ECRI investigates potential concerns and when appropriate, alerts manufacturers, providers, and regulators to help improve safety.

As AI adoption continues to grow, reporting real-world issues can help identify emerging risks, support organizational learning, and strengthen safeguards.

Help us advance the safe and effective use of AI across healthcare.

➡️ Submit a report or bookmark this link for later: https://hubs.ly/Q04zlTpx0

Providing effective care for veterans requires understanding the unique health experiences that can come with military s...
02/10/2026

Providing effective care for veterans requires understanding the unique health experiences that can come with military service.

Veterans may face complex physical and emotional health challenges, as well as barriers to meaningful engagement with the clinicians caring for them. Creating better healthcare experiences starts with understanding those challenges and knowing how to respond.

At the upcoming conference, Shannon Kooker, MSN, RN, CPPS, CPHQ, CIC, FAPIC will lead a session exploring practical strategies for providing more informed, holistic care to veterans—including how to:
- Recognize health risks associated with military service and veteran status
- Strengthen communication and engagement during the patient-provider encounter
- Develop action plans that support better healthcare experiences for veterans

We’re proud to see Shannon share their expertise and give back to the community by helping healthcare providers better understand and serve those who have served.

This commitment extends beyond the convention. Through ECRI’s SALUTE Program, ECRI supports veterans and military-affiliated communities by helping connect those who have served with resources and support.

📍 Boston, MA
📅 Wednesday, October 14, 2026

Learn more about the session: https://hubs.la/Q04yJD_C0

🔗 Register for the conference: https://hubs.la/Q04yJF7b0

Learn more about how ECRI supports veterans and military-affiliated communities through the SALUTE Program: https://hubs.la/Q04yJF7-0

Johns Hopkins Bloomberg School of Public Health invited ECRI to present at this year's BESAFE 2026 conference as part of...
01/10/2026

Johns Hopkins Bloomberg School of Public Health invited ECRI to present at this year's BESAFE 2026 conference as part of the panel "Beyond Pills: The Growing Threat of Falsified and Diverted Medical Devices," chaired by Manuela Dorado, MPH, of BESAFE.

Dr. Jeremy Suggs ECRI’s Director of Device Safety, joined fellow panelists Dinh Lê from Johnson & Johnson and Emily Grove from Homeland Security Investigations. He shared insights from ECRI's 2026 Top 10 Health Technology Hazards, which identified the issue as a top concern.

His recommendations for strengthening supply chain integrity include:
🔹 Enhance supplier vetting
🔹 Diversify sourcing
🔹 Encourage staff to report defects, since many issues go unreported
🔹 Track defects and analyze usage trends to spot quality problems early

Learn more: https://hubs.la/Q04yVB8C0

Address

PA

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Telephone

+16108256000

Alerts

Be the first to know and let us send you an email when ECRI posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ECRI:

Shortcuts

  • Want your practice to be the top-listed clinic?

Share